Repeat administration of high dose melphalan in relapsed myeloma
β Scribed by Mansi, JL; Cunningham, D; Viner, C; Ellis, E; Meldrum, M; Milan, S; Gore, M
- Book ID
- 109836933
- Publisher
- Nature Publishing Group
- Year
- 1993
- Tongue
- English
- Weight
- 925 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Seventeen unselected patients with relapsed or refractory multiple myeloma were treated with oral prednisolone 60 mg per m2 for five consecutive days with nine-day treatment-free intervals. Of the fourteen patients who completed at least six courses of treatment there were five good responses (Chron
## Abstract Twentyβone patients with referactory myeloma (10 primary resistant and 11 relapsed resistant) were treated with a combination of high dose methyl prednisolone and recombinant interferon alpha2b (IFNβΞ±2b). This treatment included three megaunits/m^2^ of IFNβΞ±2b three times a week for 12